Zobrazeno 1 - 10
of 144
pro vyhledávání: '"Maria Stefania, De Propris"'
Autor:
Alessandro Laganà, Matteo Totaro, Maria Laura Bisegna, Loredana Elia, Stefania Intoppa, marco Beldinanzi, Mabel Matarazzo, Mariangela di Trani, Alessandro Costa, Raffaele Maglione, Biancamaria Mandelli, Sabina Chiaretti, Maurizio Martelli, Maria Stefania De Propris
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 16, Iss 1 (2024)
Background: B-lineage acute lymphoblastic leukemias (B-ALL) harboring the t(9;22)(q34;q11)/BCR::ABL1rearrangement, represent a category with previously dismal prognosis whose management and outcome dramatically changed thanks to the use of tyrosine k
Externí odkaz:
https://doaj.org/article/e29c4b9f93a64e38ba922c03229d13d1
Autor:
Maria Laura Bisegna, Nadia Peragine, Loredana Elia, Mabel Matarazzo, Maria Laura Milani, Stefania Intoppa, Mariangela Di Trani, Francesco Malfona, Maurizio Martelli, Maria Stefania De Propris
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 16, Iss 1 (2024)
Background: B-lineage acute lymphoblastic leukemias (B-ALL) harboring rearrangements of the histone lysine [K]-Methyltransferase 2A (KMT2A) gene on chromosome 11q23 (KMT2A-r), represent a category with dismal prognosis. The prompt identification of t
Externí odkaz:
https://doaj.org/article/f3134d7558fb46a7887946e0ab5a36f8
Autor:
Francesca Fazio, Gianfranco Lapietra, Maria Zaira Limongi, Stefania Intoppa, Maria Laura Milani, Alfonso Piciocchi, Maurizio Martelli, Anna Guarini, Robin Foà, Maria Stefania De Propris, Maria Teresa Petrucci
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 15, Iss 1 (2023)
Multiple myeloma (MM) is a heterogeneous malignancy characterized by the proliferation of abnormal plasma cells in the bone marrow. Multiparametric flow cytometry (MFC) plays a role in the work-up of the disease in view of the aberrant expression of
Externí odkaz:
https://doaj.org/article/67fe67e41b334509b5a0c45a8af2f804
Autor:
Chiara Masucci, Sara Pepe, Ursula La Rocca, Veronica Zullino, Maria Stefania De Propris, Walter Barberi, Anna Paola Iori, Sabina Martelli, Franco Ruberto, Maurizio Martelli, Alice Di Rocco
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Anti-CD19 chimeric antigen receptor (CAR) T cell therapy actually represents the standard of care for multiple relapsed or refractory primary mediastinal B-cell lymphoma (r/r PMBCL). Checkpoint inhibitors, such as pembrolizumab, appear to be a safe a
Externí odkaz:
https://doaj.org/article/995cd2ff1e24409b83bc66432ff54ae1
Autor:
Alessandro Natoni, Marina Cerreto, Maria Stefania De Propris, Ilaria Del Giudice, Roberta Soscia, Nadia Peragine, Stefania Intoppa, Maria Laura Milani, Anna Guarini, Robin Foà
Publikováno v:
Haematologica, Vol 108, Iss 7 (2023)
Sialylation is the terminal addition of sialic acid to underlying glycans. It plays a prominent role in cell adhesion and immune regulation. Sialylated structures found on adhesion molecules, such as CD49d, mediate the interactions between cancer cel
Externí odkaz:
https://doaj.org/article/68c82e66d14042ecacf9ba4577f0f618
Autor:
Francesca R. Mauro, Irene Della Starza, Monica Messina, Gianluigi Reda, Livio Trentin, Marta Coscia, Paolo Sportoletti, Lorella Orsucci, Valentina Arena, Gloria Margiotta Casaluci, Roberto Marasca, Roberta Murru, Luca Laurenti, Fiorella Ilariucci, Caterina Stelitano, Donato Mannina, Massimo Massaia, Gian Matteo Rigolin, Lydia Scarfò, Monia Marchetti, Luciano Levato, Monica Tani, Annalisa Arcari, Gerardo Musuraca, Marina Deodato, Piero Galieni, Valeria Belsito Patrizi, Daniela Gottardi, Anna Marina Liberati, Annamaria Giordano, Maria Chiara Molinari, Daniela Pietrasanta, Veronica Mattiello, Andrea Visentin, Candida Vitale, Francesco Albano, Antonino Neri, Lucia Anna De Novi, Maria Stefania De Propris, Mauro Nanni, Ilaria Del Giudice, Anna Guarini, Paola Fazi, Marco Vignetti, Alfonso Piciocchi, Antonio Cuneo, Robin Foà
Publikováno v:
Haematologica, Vol 108, Iss 8 (2023)
The GIMEMA phase II LLC1518 VERITAS trial investigated the efficacy and safety of front-line, fixed-duration venetoclax and rituximab (VenR) in combination in young (≤65 years), fit patients with chronic lymphocytic leukemia and unmutated IGHV and/
Externí odkaz:
https://doaj.org/article/73c9f2e5b0f54fd5b553474459ac760b
Autor:
Maria Laura Bisegna, Maria Assunta Limongiello, Stefano Fiori, Maria Stefania De Propris, Irene Della Starza, Stefania Trasarti
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 15, Iss 1 (2023)
Heavy chain diseases are rare B-cell neoplasms consisting of the production of a monoclonal immunoglobulin composed of the only heavy chain without corresponding light chains. It is a rare adult disease that may involve several sites with a variable
Externí odkaz:
https://doaj.org/article/361a2b12915a41d693af2a7c040d6ac0
Autor:
Maria Laura Bisegna, Niccolò Noccioli, Irene Della Starza, Alice Di Rocco, Nadia Peragine, Maria Stefania De Propris
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 14, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/27f63a8a1fa9405e9b5ff772b6d0798d
Autor:
Luciana Cafforio, Sara Raponi, Luca Vincenzo Cappelli, Caterina Ilari, Roberta Soscia, Maria Stefania De Propris, Paola Mariglia, Gian Matteo Rigolin, Antonella Bardi, Nadia Peragine, Alfonso Piciocchi, Valentina Arena, Francesca Romana Mauro, Antonio Cuneo, Anna Guarini, Robin Foa, Ilaria Del Giudice
Publikováno v:
Haematologica, Vol 107, Iss 1 (2021)
Externí odkaz:
https://doaj.org/article/4adefec828754d3ead40696f7f652071
Autor:
Maria Cristina Puzzolo, Ilaria Del Giudice, Nadia Peragine, Paola Mariglia, Maria Stefania De Propris, Luca Vincenzo Cappelli, Livio Trentin, Gianluigi Reda, Antonio Cuneo, Stefano Molica, Alfonso Piciocchi, Valentina Arena, Francesca Romana Mauro, Anna Guarini, Robin Foà
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Ibrutinib may revert the T-helper (Th)2 polarization observed in chronic lymphocytic leukemia (CLL) by targeting the IL-2-inducible kinase, that shows a significant homology with the Bruton tyrosine kinase. In the front-line GIMEMA LLC1114 trial (ibr
Externí odkaz:
https://doaj.org/article/cd628b4fa6a448cf8cad11aced4c9099